Debt-to-equity of Zivo Bioscience, Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Zivo Bioscience, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Zivo Bioscience, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -153%, a 20% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Zivo Bioscience, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -153% -26% -20% 30 Sep 2025
Q2 2025 -162% -10% -6.8% 30 Jun 2025
Q1 2025 -162% -14% -9.5% 31 Mar 2025
Q4 2024 -149% +6% +3.6% 31 Dec 2024
Q3 2024 -128% +74% +37% 30 Sep 2024
Q2 2024 -151% +184% +55% 30 Jun 2024
Q1 2024 -148% -518% -140% 31 Mar 2024
Q4 2023 -155% -271% -234% 31 Dec 2023
Q3 2023 -201% -276% -369% 30 Sep 2023
Q2 2023 -335% -392% -693% 30 Jun 2023
Q1 2023 370% +320% +632% 31 Mar 2023
Q4 2022 116% -111% -49% 31 Dec 2022
Q3 2022 75% +476% 30 Sep 2022
Q2 2022 57% +202% 30 Jun 2022
Q1 2022 51% +153% 31 Mar 2022
Q4 2021 226% +328% 31 Dec 2021
Q3 2021 -401% -298% -292% 30 Sep 2021
Q2 2021 -146% -43% -43% 30 Jun 2021
Q1 2021 -103% -1% -0.92% 31 Mar 2021
Q4 2020 -102% -1% -0.61% 31 Dec 2020
Q3 2020 -102% -1% -1.3% 30 Sep 2020
Q2 2020 -102% -1% -1% 30 Jun 2020
Q1 2020 -102% 0% -0.09% 31 Mar 2020
Q4 2019 -101% +4% +3.7% 31 Dec 2019
Q3 2019 -101% +4% +4.2% 30 Sep 2019
Q2 2019 -101% +6% +5.7% 30 Jun 2019
Q1 2019 -102% +5% +4.7% 31 Mar 2019
Q4 2018 -105% 0% -0.28% 31 Dec 2018
Q3 2018 -105% 0% +0.25% 30 Sep 2018
Q2 2018 -107% -2% -2.1% 30 Jun 2018
Q1 2018 -107% -1% -1.3% 31 Mar 2018
Q4 2017 -105% -1% -0.76% 31 Dec 2017
Q3 2017 -106% -3% -2.7% 30 Sep 2017
Q2 2017 -105% -3% -3.4% 30 Jun 2017
Q1 2017 -105% -4% -3.5% 31 Mar 2017
Q4 2016 -104% -3% -2.6% 31 Dec 2016
Q3 2016 -103% -1% -1.2% 30 Sep 2016
Q2 2016 -102% +5% +4.8% 30 Jun 2016
Q1 2016 -102% +11% +9.7% 31 Mar 2016
Q4 2015 -101% +19% +16% 31 Dec 2015
Q3 2015 -102% +24% +19% 30 Sep 2015
Q2 2015 -107% +18% +15% 30 Jun 2015
Q1 2015 -113% +6% +5.4% 31 Mar 2015
Q4 2014 -121% -6% -5.3% 31 Dec 2014
Q3 2014 -126% -15% -14% 30 Sep 2014
Q2 2014 -125% -19% -18% 30 Jun 2014
Q1 2014 -119% -12% -12% 31 Mar 2014
Q4 2013 -115% -5% -4.6% 31 Dec 2013
Q3 2013 -111% +3% +2.4% 30 Sep 2013
Q2 2013 -106% +12% +10% 30 Jun 2013
Q1 2013 -107% +17% +14% 31 Mar 2013
Q4 2012 -110% 31 Dec 2012
Q3 2012 -113% 30 Sep 2012
Q2 2012 -118% 30 Jun 2012
Q1 2012 -124% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.